ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984

More Debate Due On Organ Site Program; First Round Reviewed By DRG “Slaughtered”

January 28, 1983

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

White House Picks Harold Varmus For NCI

May 21, 2010

Adriamycin Fact Sheet Available

July 4, 1975

Funding Opportunities.

May 10, 2002